Correlation Between Roche Holding and Astellas Pharma

Can any of the company-specific risk be diversified away by investing in both Roche Holding and Astellas Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Roche Holding and Astellas Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Roche Holding AG and Astellas Pharma, you can compare the effects of market volatilities on Roche Holding and Astellas Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Roche Holding with a short position of Astellas Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Roche Holding and Astellas Pharma.

Diversification Opportunities for Roche Holding and Astellas Pharma

0.54

Correlation Coefficient

Roche Holding  Astellas Pharma

Very weak diversification

The 3 months correlation between Roche and Astellas is 0.54. Overlapping area represents the amount of risk that can be diversified away by holding Roche Holding AG and Astellas Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Astellas Pharma and Roche Holding is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Roche Holding AG are associated (or correlated) with Astellas Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Astellas Pharma has no effect on the direction of Roche Holding i.e., Roche Holding and Astellas Pharma go up and down completely randomly.

Pair Corralation between Roche Holding and Astellas Pharma

Assuming the 90 days horizon Roche Holding AG is expected to generate 1.2 times more return on investment than Astellas Pharma. However, Roche Holding is 1.2 times more volatile than Astellas Pharma. It trades about 0.26 of its potential returns per unit of risk. Astellas Pharma is currently generating about 0.03 per unit of risk. If you would invest  28,086  in Roche Holding AG on December 27, 2024 and sell it today you would earn a total of  6,914  from holding Roche Holding AG or generate 24.62% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Roche Holding AG  vs.  Astellas Pharma

Roche Holding AG

Risk-Adjusted Performance

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Roche Holding AG are ranked lower than 20 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Roche Holding reported solid returns over the last few months and may actually be approaching a breakup point.

Astellas Pharma

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Astellas Pharma are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly strong primary indicators, Astellas Pharma is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Roche Holding and Astellas Pharma

The main advantage of trading using opposite Roche Holding and Astellas Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Roche Holding position performs unexpectedly, Astellas Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Astellas Pharma will offset losses from the drop in Astellas Pharma's long position.

The idea behind Roche Holding AG and Astellas Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.